256 related articles for article (PubMed ID: 30145692)
1. NRAS
Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
[TBL] [Abstract][Full Text] [Related]
2. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
Kolin DL; Geddie WR; Ko HM
Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
[No Abstract] [Full Text] [Related]
3. NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
Angelino G; De Pasquale MD; De Sio L; Serra A; Massimi L; De Vito R; Marrazzo A; Lancella L; Carai A; Antonelli M; Giangaspero F; Gessi M; Menchini L; Scarciolla L; Longo D; Mastronuzzi A
BMC Cancer; 2016 Jul; 16():512. PubMed ID: 27439913
[TBL] [Abstract][Full Text] [Related]
4. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
5. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
Mitre V; Heym K; Clark GD; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal melanomatosis associated with neurocutaneous melanosis: an autopsy case report.
Matsumura M; Okudela K; Tateishi Y; Umeda S; Mitsui H; Suzuki T; Nakayama T; Inayama Y; Ohashi K
Pathol Int; 2015 Feb; 65(2):100-5. PubMed ID: 25521302
[TBL] [Abstract][Full Text] [Related]
7. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
[TBL] [Abstract][Full Text] [Related]
8. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
[TBL] [Abstract][Full Text] [Related]
9. Neurocutaneous melanomatosis with a rapidly deteriorating course.
Chu WC; Lee V; Chan YL; Shing MM; Chik KW; Li CK; Ma KC
AJNR Am J Neuroradiol; 2003 Feb; 24(2):287-90. PubMed ID: 12591651
[TBL] [Abstract][Full Text] [Related]
10. [Melanocytic Tumors].
Okamoto K; Natsumeda M; Oishi M; Fujii Y
No Shinkei Geka; 2021 Mar; 49(2):389-394. PubMed ID: 33762462
[TBL] [Abstract][Full Text] [Related]
11. [Melanocytoma and meningeal melanocytosis, similar but different lesions].
Padilla-Vázquez F; Escobar-de la Garma VH; Ayala-Arcipreste A; Mendizábal-Guerra R; Cuesta-Mejía T
Cir Cir; 2017; 85(3):273-278. PubMed ID: 28126183
[TBL] [Abstract][Full Text] [Related]
12. Spinal neurocutaneous melanosis without cutaneous nevi.
Asanuma K; Kasai Y; Takegami K; Ito H; Yoshikawa T; Uchida A
Spine (Phila Pa 1976); 2008 Oct; 33(21):E798-801. PubMed ID: 18827686
[TBL] [Abstract][Full Text] [Related]
13. Primary melanocytic tumors of the central nervous system: a neuroradiological and clinicopathological study of five cases and brief review of literature.
Jaiswal S; Vij M; Tungria A; Jaiswal AK; Srivastava AK; Behari S
Neurol India; 2011; 59(3):413-9. PubMed ID: 21743173
[TBL] [Abstract][Full Text] [Related]
14. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.
Küsters-Vandevelde HV; Küsters B; van Engen-van Grunsven AC; Groenen PJ; Wesseling P; Blokx WA
Brain Pathol; 2015 Mar; 25(2):209-26. PubMed ID: 25534128
[TBL] [Abstract][Full Text] [Related]
15. Supratentorial intermediate grade meningeal melanocytoma with intratumoral bleed in the background of neurocutaneous melanosis: Report of an unusual case and review of literature.
Das K; Nair A; Jaiswal S; Sahu R; Srivastava A; Kumar R; Mehrotra A
Asian J Neurosurg; 2017; 12(1):98-102. PubMed ID: 28413547
[TBL] [Abstract][Full Text] [Related]
16. Primary Diffuse Leptomeningeal Melanomatosis of Spine: 18F-FDG PET Findings.
Ayan A; Akbulut A; Deveci G; Koca G
Clin Nucl Med; 2019 Feb; 44(2):137-139. PubMed ID: 30516687
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal melanocytosis in an adult male without large congenital nevi: a rare and atypical case of neurocutaneous melanosis.
Sutton BJ; Tatter SB; Stanton CA; Mott RT
Clin Neuropathol; 2011; 30(4):178-82. PubMed ID: 21726502
[TBL] [Abstract][Full Text] [Related]
18. Primary melanocytic neoplasms of the central nervous system.
Liubinas SV; Maartens N; Drummond KJ
J Clin Neurosci; 2010 Oct; 17(10):1227-32. PubMed ID: 20558070
[TBL] [Abstract][Full Text] [Related]
19. AN 11-Year-Old Boy with a Leptomeningeal Tumor.
Habougit C; Forest F; Boutet C; Douchet C; Stephan JL; Stachowicz ML; Vassal F; Péoc'h M
Brain Pathol; 2017 Jul; 27(4):553-554. PubMed ID: 28585389
[No Abstract] [Full Text] [Related]
20. Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.
Takahashi H; Natsumeda M; Hara N; Koyama A; Shimizu H; Miyashita A; Satake D; Mouri Y; Tsukano J; Kawabe K; Tsukamoto Y; Okada M; Ogura R; Yuki A; Umezu H; Kakita A; Ikeuchi T; Oishi M
Acta Neuropathol Commun; 2024 Jan; 12(1):14. PubMed ID: 38254245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
